	Prognostic and Predict Value of Peripheral Blood Circulating Tumor Cells Programmed Death-Ligand 1 Expression and F-18-Fluorodeoxyglucose Metabolic Parameters in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors. Cancer Med Sun M, Aikedan A, Rui Z, Ding E, Shen J. PMID: 42267455 [PubMed - in process]
	Ki67 proliferation index augments two-tier tumour grade in prediction of survival and progression-free survival in epithelioid pleural mesothelioma. ERJ Open Res Lynch GA, Zhang YZ, Bhatt N, Charters P, Aujayeb A, Walker S, Symonds J, Clive AO, Bhatnagar R, Morley A, White P, Nicholson AG, Maskell NA, Bibby A. PMID: 42267369 [PubMed]
	Lung cancer in never-smoking females: epidemiology, risk factors and screening. Front Public Health Ding Y, Tao H, Zhu C, Li H, Zhang Y, Du Y, Du L, Gong W, Wang L. PMID: 42267273 [PubMed - in process]
	Radon Exposure as an Occupational Hazard and Environmental Risk Factor for Lung Cancer in Utah: Assessment, Mitigation, and Policy Implications. J Registry Manag Daramola O. PMID: 42267114 [PubMed - in process]
	HHLA2 as an emerging immune checkpoint in lung cancer: linking EGFR signaling, macrophage polarization, and CD8(+) T-cell metabolic suppression. Front Immunol Wang J, Wang K, Hu Z, Hu X. PMID: 42266686 [PubMed - in process]
	Combining Commercial Cancer Protein Biomarkers and Benign Fungal Antibodies Improves Diagnostic Accuracy in Pulmonary Nodules. Ann Surg Holmes HM, McGann KC, Chen SC, Welch C, Zou Y, Antic S, Forero YJ, Argaw SA, Chen H, Kaizer A, Baron A, Meguid R, Maldonado F, Deppen SA, Grogan EL. PMID: 42265763 [PubMed - as supplied by publisher]
	Multiomics integration prioritizes potential drug targets for lung cancer. Discov Oncol Meng P, Zhang Z, Ruan Z, Xu C. PMID: 42265473 [PubMed - as supplied by publisher]
	Observational study of predictors and outcomes of lung cancer in never-smokers in the UK (OLIVE): study protocol. BMJ Open Respir Res Naidu SB, Guvensen G, Wu H, Omar RZ, Menon U, Popat S, Moore DA, Soo Y, Bhamani A, Thakrar R, Ahmad T, Ppi Group O, Janes SM, Forster MD, Navani N. PMID: 42264884 [PubMed - in process]
	Minimally Invasive/Robotic Surgery for Lung Cancer. Surg Oncol Clin N Am Wheelwright M, Su KW, Krantz SB. PMID: 42264693 [PubMed - in process]
	STAGE II NON-SMALL CELL LUNG CANCER: UPFRONT SURGERY OR NEOADJUVANT CHEMOIMMUNOTHERAPY. Ann Thorac Surg Tajè R, Gallina FT, Spicer JD. PMID: 42264017 [PubMed - as supplied by publisher]
	TROP2 as a Promising Therapeutic Target in Lung Cancer: Current Clinical Trial Landscape and Future Directions. Pulm Pharmacol Ther Liu M, Luo R, Liu Y, Fan Y, Zhang J, Liu M. PMID: 42263842 [PubMed - as supplied by publisher]
	Palladium nanoparticles in lung cancer: Emerging strategies for diagnosis and therapeutic intervention. Pathol Res Pract Swarn S, Parmar V, Sharma SK, Saini V, Prajapati BG, Alsaidan OA, Alzarea SI, Kapoor DU. PMID: 42263463 [PubMed - as supplied by publisher]
	Differentiating benign from malignant pulmonary nodules in the context of bronchiectasis: a retrospective study. Ann Med Wang L, Yang D, Zhou X, Guo T, Liu L, Lei C, Luo H. PMID: 42262976 [PubMed - indexed for MEDLINE]
	Laryngeal leiomyosarcoma: A rare case report and literature review. Oncotarget Shalabaev B, Kurash S, Nurzhanov A, Serikbaiuly D, Kochiev B, Manatova A, Burkitbayev Z, Kuanysh Z. PMID: 42262152 [PubMed - indexed for MEDLINE]
	Analyzing the Influence of Surgical Sequence on Perioperative Circulating Tumor Cells in Patients with Resectable Non-Small Cell Lung Cancer. Cancer Manag Res Chen H, He Y, Wang Y, Liu X, Zou G. PMID: 42261330 [PubMed]
	LEPR Contributes to Lung Squamous Cell Carcinoma: Insights From Mendelian Randomization and Experimental Studies. Cancer Inform Hu W, Wu G, Lin Y, Li S, Lin Z, Chen Y, Cheng Z, Zeng J, Yang Z, Wang Y. PMID: 42261303 [PubMed]
	Prognostic role of the systemic immune-inflammation in patients with non-small cell lung cancer: A meta-analysis. J Pak Med Assoc Zhao G, Zhang H, Ye P, Chen W. PMID: 42261026 [PubMed - in process]
	miR-130a-3p regulates the occurrence and progression of lung squamous cell carcinoma by activating ZDHHC5 and immune cell-related pathways. Medicine (Baltimore) Li W, Xia B, Deng S. PMID: 42260863 [PubMed - in process]
	Addressing Data Quality Challenges in Lung Cancer Data Within the Observational Medical Outcomes Partnership Common Data Model: Observational Study. J Med Internet Res Declerck J, Deschepper M, Colpaert K, Kalra D, Coorevits P. PMID: 42258805 [PubMed - in process]
	Predicting 5-Year Mortality in Non-Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study. JMIR Med Inform Lee JH, Kim HC, Jung KW, Choi CM. PMID: 42258797 [PubMed - in process]

Articles 1 - 20 / 159301

Page 1 of 7966



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy